Envestnet Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Envestnet Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,903	Closed	-$209K	–	3237
2016 Q1	$209K	Sell	3,903 -90	-2%	-$6.64K	﹤0.01%	2042
2015 Q4	$451K	Buy	3,993 +2,373	+146%	+$261K	﹤0.01%	1652
2015 Q3	$191K	Buy	+1,620	New	+$212K	﹤0.01%	2025
2014 Q3	–	Sell	-207	Closed	-$4K	–	3018
2014 Q2	$4K	Buy	+207	New	+$3.33K	﹤0.01%	2409

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Envestnet Asset Management's ANAC Position: Q2 2016 in Review

Envestnet Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 3,903 shares — an estimated $209K sold.

Envestnet Asset Management first reported a position in ANAC in Q2 2014 and held it in 4 quarters. The position peaked at $451K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Envestnet Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Envestnet Asset Management sold 3,903 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $209K.
Envestnet Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 4 quarters.
Envestnet Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $451K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Envestnet Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.